ALYMSYS vs AXTLE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. ALYMSYS and AXTLE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALYMSYS	AXTLE
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BEVACIZUMAB-MALY	PEMETREXED DIPOTASSIUM
Manufacturer	Amneal	Avyxa Holdings
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms	Malignant Mesothelioma, Non-Small-Cell Lung Carcinoma, Lung Neoplasms

alymsys axtle

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

BEVACIZUMAB-MALY

PEMETREXED DIPOTASSIUM

Manufacturer

Amneal

Avyxa Holdings

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Malignant Mesothelioma, Non-Small-Cell Lung Carcinoma, Lung Neoplasms

Frequently asked questions

What is the difference between Alymsys and Axtle?

Alymsys contains Bevacizumab-Maly, while Axtle contains Pemetrexed Dipotassium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.